The Food and Drug Administration had previously granted an emergency use authorization for Abbott’s ID NOW point-of-care test, a decision for which the agency came under fire amid reports of the test delivering inaccurate results.
Success requires both novel VBC models as well as moving care beyond the clinic walls to meet patients where they are.
Headspace is going toe-to-toe with the likes of Talkspace and BetterHelp by bringing its mental health services directly to consumers — starting with text-based mental…
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Headspace is going toe-to-toe with the likes of Talkspace and BetterHelp by bringing its mental health services directly to consumers — starting with text-based mental…
ImmunityBio therapy Anktiva is now FDA approved for treating patients with non-muscle invasive bladder cancer. The novel immunotherapy works by sparking activity from three types…
Smart but easy tech upgrades can boost margins.
No passing fad, AI in healthcare is here, and it’s already improving the lives of patients, healthcare workers, and researchers. How can we make a…
Welcome to Debunked, where we slaughter myths, bad practices, and sacred cows in healthcare. In this episode, we talk about the massive cyberattack at Change…
Join us to hear from innovative investors and entrepreneurs offering novel approaches to solve some of healthcare’s greatest challenges.
It can be tiring pretending to be someone you’re not. For many neurodivergent people at work, this is an everyday reality — and it’s burning…
